WebDisclosure WebDisclosure
Basculer en Français
9562 Companies
188958 Keywords
120655 Articles
100824 Press releases
Headlines Articles Press releases GEN İlaç Ve Sağlık Ürünleri A.Ş. Remove
  1. Home
  2. Companies
  3. GEN İlaç Ve Sağlık Ürünleri A.Ş.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/25/2024 at 15:05, 1 year 2 months ago

    GEN Reports Positive Phase 2 Trial Results for GN-037 Topical Cream

    Clinical Efficacy Phase 2 Trial Results GN-037 Topical Cream Plaque Psoriasis Treatment GEN Pharmaceuticals
  • BRIEF

    published on 09/25/2024 at 15:05, 1 year 2 months ago

    GEN annonce des résultats positifs de l'essai de phase 2 pour la crème topique GN-037

    Efficacité Clinique Résultats De L'essai De Phase 2 Crème Topique GN-037 Traitement Du Psoriasis En Plaques GEN Pharmaceutique
  • PRESS RELEASE

    published on 09/25/2024 at 15:00, 1 year 2 months ago

    GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis

    GEN Pharmaceuticals announces positive Phase 2 trial results for GN-037 topical cream in treating plaque psoriasis, presented at EADV Congress 2024
    Phase 2 Trial GN-037 Topical Cream GEN Pharmaceuticals Plaque Psoriasis EADV Congress
    Logo of GEN İlaç Ve Sağlık Ürünleri A.Ş.
Accesswire
  • Published on 12/22/2025 at 08:05, 1 hour 48 minutes ago

    Tocvan Begins Trenching Material for the Pilot Mine and Pushes Ahead With Infrastructure Development

  • Published on 12/20/2025 at 00:30, 2 days 9 hours ago

    Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025

  • Published on 12/19/2025 at 22:00, 2 days 11 hours ago

    GMV Minerals Inc. Closes Non-Brokered Equity Financing

  • Published on 12/19/2025 at 18:30, 2 days 15 hours ago

    Eagle Plains Shareholders Approve all Matters at Annual General Meeting

  • Published on 12/19/2025 at 14:40, 2 days 19 hours ago

    Northern Superior Announces Closing of the Arrangement

View all ACCESSWIRE
EQS Group
  • Published on 12/22/2025 at 09:30, 22 minutes ago

    Huawei's MoM-based Multi-Agent Collaboration System Empowers Core Networks' Transitioning to L4 High Stability

  • Published on 12/22/2025 at 09:22, 31 minutes ago

    Heirs Energies Agrees $750m Afreximbank Financing to Drive Long-Term Growth

  • Published on 12/22/2025 at 09:22, 31 minutes ago

    Heirs Energies conclut un accord de financement de 750 millions USD avec Afreximbank pour stimuler sa croissance à long terme

  • Published on 12/22/2025 at 09:19, 33 minutes ago

    INDUS acquires media technology specialist

  • Published on 12/22/2025 at 09:00, 52 minutes ago

    Original-Research: Cantourage Group SE (von NuWays AG): BUY

View all EQS
Les Echos
  • Published on 12/22/2025 at 09:18, 34 minutes ago

    GUILLEMOT CORPORATION: Information regarding the total number of voting rights and shares 11/12/2025

  • Published on 12/22/2025 at 09:18, 34 minutes ago

    GUILLEMOT CORPORATION : Informations relatives au nombre total de droits de vote et d’actions 11/12/2025

  • Published on 12/19/2025 at 21:57, 2 days 11 hours ago

    Mise à disposition du document d’enregistrement universel

  • Published on 12/19/2025 at 08:30, 3 days 1 hour ago

    Share capital decrease by way of treasury shares cancellation

  • Published on 12/19/2025 at 08:30, 3 days 1 hour ago

    Réduction du capital par voie d’annulation d’actions propres

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy